OrganiCare Raises $8.5M in Series A Funding

FemiClear for Genital Herpes Symptoms, a product of OrganiCare

OrganiCare, an Austin TX-based provider of healthcare products, raised $8.5M in Series A funding.

Backers include Jake Moilanen, General Partner at Seraph Group.

The company intends to use the funds to build the FemiClear brand awareness and bring additional product innovation to market.

Founded in 2016 in Austin, Texas and led by Caroline Goodner, OrganiCare provides healthcare products that contain only natural ingredients. Its range of products, under the CUROXEN and FemiClear brands, are distributed in many national and regional drug, mass, food and e-commerce retailers.

FemiClear for Genital Herpes Symptoms is available at CVS, Walmart, Rite Aid, Amazon, and other national drug and food retailers.